NEW YORK, Nov. 5, 2013 /PRNewswire-USNewswire/ -- The American Committee for the Weizmann Institute of Science announced today that Nancy and Stephen Grand of San Francisco have committed $50 million to advance the international study of personalized medicine.
The funds will be used by the Weizmann Institute of Science in Rehovot, Israel, to operate the recently established Israel National Center for Personalized Medicine (INCPM). The Grand gift is the single largest contribution ever made to the American Committee in its 70-year history supporting scientific research and science education.
As the only facility of its kind in Israel and in the region, the Nancy and Stephen Grand Israel National Center for Personalized Medicine is a state-of-the-art biomedical research center focused on four innovative fields: genomics, protein profiling, bioinformatics, and drug discovery. Personalized and predictive medicine uses information about a person's genes, proteins, and personal history to prevent, diagnose, and treat disease.
The Nancy and Stephen Grand Israel National Center for Personalized Medicine is located on the campus of the Weizmann Institute with a national steering committee headed by Aaron Ciechanover, the 2004 Nobel Prize winner in Chemistry. The Center is a national consortium led by a steering committee including representatives from major universities, hospitals, and the biotechnology sector in Israel. It serves Israel's life sciences research community, universities, hospitals, and other researchers in the pharmaceutical, biotechnology, and biomedical industries. The Center will collaborate with researchers from leading institutions abroad, and will offer the advantage of drawing upon Israel's d
|SOURCE American Committee for the Weizmann Institute of Science|
Copyright©2012 PR Newswire.
All rights reserved